slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,471
Current window 34,831-34,860
Pages 3,950
Rows per page 30
Component
34,831-34,860 of 118,471
408
The slide uses direct quotes from an endocrinologist to frame potential medical risks as a barrier to adoption.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
410
The slide uses Q&A transcripts to highlight the expert's skepticism regarding Vykat's value proposition.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
411
The slide uses a Q&A format to highlight the administrative burden and slow approval process for the drug Vykat.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
413
The slide uses a Q&A format to present primary research findings from a consultation call.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
04
The slide uses a forensic accounting framework to explain how inventory manipulation leads to overstated earnings.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The Monster2 hits
29
The slide uses a Q&A format to highlight specific allegations from an industry executive regarding OIG, DOJ, and IRS involvement.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Exposure of Contradictions2 hits
35
The slide uses a narrative approach to cast doubt on the reputation of a prominent surgeon, linking him to high mortality rates and unethical practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
40
The slide uses a Q&A transcript format to highlight potential regulatory and ethical misconduct.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
43
The slide presents a narrative of corporate misconduct/extortion based on a letter from a politician.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
44
The slide contains two paragraphs of text that are largely redundant, summarizing the same allegation. The source is a Daily Caller article referencing a letter from Feb 21, 2024.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
45
The slide presents a narrative of corporate malfeasance by quoting a letter from a politician and contrasting it with alleged CEO statements.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
54
The slide uses Q&A transcript excerpts to build a negative narrative about the company's business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
57
The slide uses a 'he-said, she-said' structure to frame the company's NOP service as a potential antitrust issue.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
65
The slide uses a Q&A format to highlight alleged anti-competitive behavior (tying/bundling).TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
68
The slide uses a Q&A transcript format to build a narrative of extortion.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
72
The slide uses a Q&A format to validate the claims of systematic fraud.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
79
The slide uses a Q&A format to build credibility and expose operational inefficiencies.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
81
The slide uses a combination of summary text and a direct, highlighted quote from a UCSF administrator to substantiate claims of fraudulent billing.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
104
The slide uses a Q&A transcript format to highlight defensive behavior from a subject.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
106
The slide uses a Q&A format to highlight potential ethical concerns regarding stock ownership and consulting arrangements.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
116
Contains highlighted text segments within the quotes.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
119
The slide uses a Q&A format to build a case of corporate malfeasance or regulatory avoidance.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
122
The slide uses a Q&A transcript format to substantiate claims of industry-wide corruption and ongoing investigations.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
123
The slide uses a Q&A transcript format to substantiate claims of kickbacks in the organ transport industry.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
133
The slide presents a narrative of systemic corruption and regulatory bypass involving TransMedics and OPOs.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
142
Includes a Q&A transcript excerpt highlighting potential ethical/regulatory concerns regarding organ allocation and communication methods.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
144
Includes a Q&A transcript excerpt as evidence for the allegations.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
148
The slide uses a Q&A format to highlight alleged unethical business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
150
The slide uses a Q&A transcript format to highlight potential ethical concerns regarding vendor access to sensitive medical data.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
151
The slide presents two Q&A excerpts from a transplant surgeon to support the claim that TransMedics is hijacking the organ allocation process.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits